iShares Trust iShares iBonds 1-5 Year Treasury Ladder ETF (ARCA: LDRT)

Latest news for iShares Trust iShares iBonds 1-5 Year Treasury Ladder ETF (ARCA:LDRT)

iShares iBonds 1-5 Year Treasury Ladder ETF

iShares Trust iShares iBonds 1-5 Year Treasury Ladder ETF

<p>Keefe, Bruyette &amp; Woods  analyst Jade Rahmani   maintains Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) with a Market Perform and lowers the price target from $164 to $132.</p>


News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Market Perform on Toll Brothers, Lowers Price Target to $132

Guidance

NIXX

NIXXY Anticipates Monthly Revenue Run Rate Of Approximately $25M-$27M; Says Targeting Market Expansion And Acquisitions

Biotech

General

TLSA

Tiziana Life Sciences Announces Nasal Anti-CDC Preclinical Study For Treating Long Covid Study Is Nearing Completion

<p>Needham  analyst Ryan Koontz   reiterates Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) from Hold to Hold.</p>


Reiteration

Needham Reiterates Hold on Zoom Communicationsto Hold

<p>Under the terms of the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Bancorp Financial stockholders will receive 2.5814 shares of Old Second common stock and $15.93 in cash for each share of Bancorp Financial's common stock, for total consideration consisting of approximately 75% stock and 25% cash. Based on the closing price of Old Second common stock of $18.08 per share on February 24, 2025, the implied purchase price is $62.60 per Bancorp Financial common share, with an aggregate transaction value of approximately $197 million.</p>


OSBC

Old Second Bancorp Expands With Evergreen Bank Acquisition, Valued At $197M In Cash-And-Stock Transaction

<p>Needham  analyst John Todaro   maintains Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) with a Buy and lowers the price target from $16 to $13.5.</p>


RIOT

Needham Maintains Buy on Riot Platforms, Lowers Price Target to $13.5

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">148.300</td>
<td align="right">0.680</td>
<td align="right">0.46</td>
<td>5.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.120</td>
<td align="right">0.150</td>
<td align="right">0.29</td>
<td>135.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.060</td>
<td align="right">0.190</td>
<td align="right">0.23</td>
<td>39.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">82.610</td>
<td align="right">0.180</td>
<td align="right">0.21</td>
<td>2.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">91.031</td>
<td align="right">0.081</td>
<td align="right">0.08</td>
<td>11.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">231.630</td>
<td align="right">0.120</td>
<td align="right">0.05</td>
<td>15.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">134.290</td>
<td align="right">0.060</td>
<td align="right">0.04</td>
<td>438</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">217.03</td>
<td align="right">-0.54</td>
<td align="right">-0.25</td>
<td>835</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">42.38</td>
<td align="right">-0.04</td>
<td align="right">-0.10</td>
<td>3.0K</td>
</tr>
</tbody>
</table>
<p><a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. </p>
<p><em>For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.</em> </p>


Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For February 25, 2025

ONVO

Lilly To Acquire Organovo's FXR Program, Including FXR314; Terms Not Disclosed

<p><i>– Priority review reduces the BLA review timeline to 6-months and is granted to therapies that, if approved, would provide significant improvements in the treatment, diagnosis or prevention of serious conditions –</i></p>
<p><i>– If approved, PRGN-2012 would be the first and only available FDA-approved therapy for eligible patients with RRP, a rare and devastating chronic disease for which the current standard-of-care is repeated surgeries –```</i></p>


PGEN

FDA Grants Pricgen Priority Review For Its Biologics License Application for PRGN-2012 For Treatment Of Adults with Recurrent Respiratory Papillomatosis

<p>Keefe, Bruyette &amp; Woods  analyst Tommy McJoynt   maintains MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) with a Outperform and lowers the price target from $22 to $19.</p>


Keefe, Bruyette & Woods Maintains Outperform on MediaAlpha, Lowers Price Target to $19

<p>Needham  analyst David Saxon   maintains SI-BONE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) with a Buy and raises the price target from $20 to $24.</p>


SIBN

Needham Maintains Buy on SI-BONE, Raises Price Target to $24

<p>Below is a summary of DKL's expectations for 2025:</p>
<p>Generate $480 - $520 million of Adjusted EBITDA<br /><br />Coverage ratio of approximately 1.3x by year end<br /><br />Invest $220 - $250 million in capital expenditures, including expansion projects<br /><br />Expect to continue growing the distributions in 2025</p>


Delek Logistics 2025 Outlook: Expects Adjusted EBITDA Of $480-$520M And Sees $220M-$250M Capital Expenditures

CADL

Candel Therapeutics Final Survival Data From Randomized Controlled Phase 2 Clinical Trial CAN-2409 In Non-Metastatic Pancreatic Cancer Showing Improvement In Estimated Median Overall Survival Of 31.4 Months After Treatment vs 12.5 Months In Control Group

<p>Keefe, Bruyette &amp; Woods  analyst Jade Rahmani   maintains Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) with a Market Perform and lowers the price target from $13.5 to $12.</p>


Keefe, Bruyette & Woods Maintains Market Perform on Arbor Realty Trust, Lowers Price Target to $12

<p>Keefe, Bruyette &amp; Woods  analyst Paul Johnson   initiates coverage on MSC Income Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSIF#NYSE">MSIF</a>) with a Market Perform rating and announces Price Target of $17.5.</p>


Initiation

MSIF

Keefe, Bruyette & Woods Initiates Coverage On MSC Income Fund with Market Perform Rating, Announces Price Target of $17.5

<p>Portillos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.06 by 183.33 percent. This is a 30.77 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $184.61 million which missed the analyst consensus estimate of $185.87 million by 0.68 percent. This is a 1.73 percent decrease over sales of $187.86 million the same period last year.</p>


PTLO

Portillos Q4 EPS $0.17 Beats $0.06 Estimate, Sales $184.61M Miss $185.87M Estimate

OPAL

OPAL Fuels Acquires A Public Fueling Station, Terms Not Disclosed

Rithm Property Trust Commences A Public Offering Of Shares Of The Company's Series C Fixed-to-Floating Cumulative Redeemable Preferred Stock

SLNH

Soluna Holdings Secures Land Purchase Agreement To Build Its Project Rosa Data Center

<p><strong>FIRST HALF 2025 GUIDANCE</strong></p>
<p>The Company plans between $185 and $195 million in capital expenditures (including approximately $24 million for exploration/appraisal drilling and $11 million for waterflood projects) plus an additional $11 to $12 million in decommissioning expenditures in the first half of 2025. First half production is expected to average approximately 33,800 boe/d (midpoint of guidance) - a three percent decrease from 35,006 boe/d in the first half of 2024, primarily due to the disposition Transaction1 that results in the net sale of approximately 10,000 boe/d of production. Peace River average production is expected to remain relatively flat over the first half of 2025 as many of our wells will not be onstream until the second quarter and several exploration wells will be shut in after evaluation due to seasonal access constraints. As a result, the majority of 2025 production gains will be realized during the second half of the year.</p>
<p>In the first half of 2025, net operating costs per boe are expected to be higher than 2024 levels due to increased trucking costs associated with our Peace River development and the benefit of reduced operating costs from the Transaction not occurring until the second quarter. Our 2025 guidance is based on lower commodity prices than in 2024, consisting of US$71.00/bbl WTI, US$5.00/bbl MSW differential, US$14/bbl WCS differentials and $2.00/GJ AECO natural gas. Our plan anticipates FFO of approximately $180 million, and a net debt to FFO ratio of approximately 0.7 times (based on annualized first half FFO and excluding any value for the InPlay share position from the Transaction).</p>


Comments

iShares Trust iShares iBonds 1-5 Year Treasury Ladder ETF

News

Latest news for iShares Trust iShares iBonds 1-5 Year Treasury Ladder ETF (ARCA:LDRT)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga